Transcripts

Innate Pharma (IPHA) earnings call transcripts

Earnings call transcripts for Innate Pharma S.A., with a summary, the guidance given, and what analysts pressed on.

  • Q4 2026 earnings call

    Management framed the half around executing three catalysts, with the SOBI deal strengthening funding and early ADC activity still awaiting fuller data.

    Date n/aPositive0.68